Genetic variations in magnesium-related ion channels may affect diabetes risk among African American and hispanic American women

Journal of Nutrition

Volumn 145, Issue 3, 2015, Pages 418-424

  K Chan, Kei Hang ^a   Chacko, Sara A ^b   Song, Yiqing ^c   Cho, Michele ^d   Eaton, Charles B ^a,e   Wu, Wen Chih H ^a,f   Liu, Simin ^a,d,g  

^a BROWN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^f PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g RHODE ISLAND HOSPITAL   (United States)

Author keywords

Diabetes; Genes; Ion channel; Magnesium intake; Women

Indexed keywords

CLAUDIN 16; CLAUDIN 19; CYCLIN MEDIATOR 1; CYCLIN MEDIATOR 2; FXYD DOMAIN CONTAINING ION TRANSPORT REGULATOR 2; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; ION CHANNEL; MAGNESIUM; MEMBRANE MAGNESIUM TRANSPORTER 1; MITOCHONDRIAL RNA; MITOCHONDRIAL RNA SPLICING 2 PROTEIN; NONIMPRINTED PRADER WILLI ANGELMAN SYNDROME 1; NONIMPRINTED PRADER WILLI ANGELMAN SYNDROME 2; ORAL ANTIDIABETIC AGENT; PROTEIN ABCC8; SODIUM CHLORIDE COTRANSPORTER; SOLUTE CARRIER FAMILY 41 MEMBER 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; UNCLASSIFIED DRUG; ZINC FINGER DHHC TYPE CONTAINING 17; CATION TRANSPORT PROTEIN; CLAUDIN; CLDN19 PROTEIN, HUMAN; INWARDLY RECTIFYING POTASSIUM CHANNEL; SLC41A1 PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HISPANIC; HUMAN; MAGNESIUM INTAKE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; POSTMENOPAUSE; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; BODY MASS; CASE CONTROL STUDY; DIET SUPPLEMENTATION; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE; MIDDLE AGED; RISK FACTOR; STATISTICAL MODEL;

AFRICAN AMERICANS; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CLAUDINS; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPING TECHNIQUES; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; ION CHANNELS; LOGISTIC MODELS; MAGNESIUM; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84928394324     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.203489     Document Type: Article

References (37)

1. Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004;27:134-40.
2. Song Y, Hsu YH, Niu T, Manson JE, Buring JE, Liu S. Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women. BMC Med Genet 2009;10:4-15.
3. Romero JR, Castonguay AJ, Barton NS, Germer S, Martin M, Zee RY. Gene variation of the transient receptor potential cation channel, subfamily M, members 6 (TRPM6) and 7 (TRPM7), and type 2 diabetes mellitus: a case-control study. Transl Res 2010;156:235-41.
4. Ashcroft FM, Harrison DE, Ashcroft SJ. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature 1984;312:446-8.
5. Gloyn AL, Siddiqui J, Ellard S. Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 2006;27:220-31 10.1002/humu.20292.
6. Gribble FM, Tucker SJ, Haug T, Ashcroft FM. MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci USA 1998;95:7185-90.
7. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998;19:61-109.
8. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
9. Thornton T, McPeek MS. ROADTRIPS: case-control association testing with partially or completely unknown population and pedigree structure. Am J Hum Genet 2010;86:172-84.
10. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genomewide association studies. Nat Genet 2006;38:904-9.
11. Benjamini Y, H. Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
12. Hsu YH, Niu T, Song Y, Tinker L, Kuller LH, Liu S. Genetic variants in the UCP2-UCP3 gene cluster and risk of diabetes in the Women's Health Initiative Observational Study. Diabetes 2008;57:1101-7.
13. R Development Core Team. R: a language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2010 [cited 2014 Sep 2]. Available from: http://wwwR-project.org.
14. Aguilar-Bryan L, Bryan J. Molecular biology of adenosine triphosphatesensitive potassium channels. Endocr Rev 1999;20:101-35.
15. Edghill EL, Flanagan SE, Ellard S. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11. Rev Endocr Metab Disord 2010;11:193-8.
16. Gloyn AL, Cummings EA, Edghill EL, Harries LW, Scott R, Costa T, Temple IK, Hattersley AT, Ellard S. Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel. J Clin Endocrinol Metab 2004;89: 3932-5.
17. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004;350:1838-49.
18. Slingerland AS, Hattersley AT. Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment. Ann Med 2005;37:186-95.
19. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, Walker M, Levy JC, Sampson M, Halford S, et al. Large-scale association studies of variants in genes encoding the pancreatic betacell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003;52:568-72.
20. Zhou D, Zhang D, Liu Y, Zhao T, Chen Z, Liu Z, Yu L, Zhang Z, Xu H, He L. The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population. J Hum Genet 2009;54:433-5.
21. Alsmadi O, Al-Rubeaan K, Wakil SM, Imtiaz F, Mohamed G, Al-Saud H, Al-Saud NA, Aldaghri N, Mohammad S, Meyer BF. Genetic study of Saudi diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes. Diabetes Metab Res Rev 2008;24: 137-40.
22. Doi Y, Kubo M, Ninomiya T, Yonemoto K, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y. Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: the Hisayama Study. Diabetes 2007;56:2829-33.
23. Gonen MS, Arikoglu H, Erkoc Kaya D, Ozdemir H, Ipekci SH, Arslan A, Kayis SA, Gogebakan B. Effects of single nucleotide polymorphisms in K(ATP) channel genes on type 2 diabetes in a Turkish population. Arch Med Res 2012;43:317-23.
24. Palmer ND, Langefeld CD, Bryer-Ash M, Rotter JI, Taylor KD, Bowden DW. Association of the Kir6.2 E23K variant with reduced acute insulin response in African-Americans. J Clin EndocrinolMetab 2008;93:4979-83.
25. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010;26:2069-70.
26. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM, et al; Wellcome Trust Case Control Consortium (WTCCC). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007;316:1336-41.
27. Chavali S, Mahajan A, Tabassum R, Dwivedi OP, Chauhan G, Ghosh S, Tandon N, Bharadwaj D. Association of variants in genes involved in pancreatic beta-cell development and function with type 2 diabetes in North Indians. J Hum Genet 2011;56:695-700.
28. Kalis M, Bolmeson C, Esguerra JL, Gupta S, Edlund A, Tormo-Badia N, Speidel D, Holmberg D, Mayans S, Khoo NK, et al. Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS One 2011;6:e29166.
29. Yogi A, Callera GE, Antunes TT, Tostes RC, Touyz RM. Vascular biology of magnesium and its transporters in hypertension. Magnes Res 2010;23:S207-15.
30. Goytain A, Quamme GA. Identification and characterization of a novel family of membrane magnesium transporters, MMgT1 and MMgT2. Am J Physiol Cell Physiol 2008;294:C495-502.
31. Goytain A, Hines RM, El-Husseini A, Quamme GA. NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter. J Biol Chem 2007;282:8060-8.
32. Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F, Wallace R, Liu S. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010;33:304-10.
33. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of theWomen's Health Initiative food frequency questionnaire. Ann Epidemiol 1999;9:178-87.
34. Meyer TE, Verwoert GC, Hwang SJ, Glazer NL, Smith AV, van Rooij FJ, Ehret GB, Boerwinkle E, Felix JF, Leak TS, et al. Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six loci influencing serum magnesium levels. PLoS Genet 2010;6:e1001045.
35. Hruby A, McKeown NM, Song Y, Djousse L. Dietary magnesium and genetic interactions in diabetes and related risk factors: a brief overview of current knowledge. Nutrients 2013;5:4990-5011.
36. Chacko SA, Song Y, Manson JE, Van Horn L, Eaton C, Martin LW, McTiernan A, Curb JD, Wylie-Rosett J, Phillips LS, et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011;94:209-17.
37. Deng X, Song Y, Manson JE, Signorello LB, Zhang SM, Shrubsole MJ, Ness RM, Seidner DL, Dai Q. Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III. BMC Med 2013;11:187-200.